Abstract
Background: Chronic lymphocytic leukemia cells are characterized by an apparent longevity in vivo which is lost when they are cultured in vitro. Cellular interactions and factors provided by the microenvironment appear essential to cell survival and may protect leukemic cells from the cytotoxicity of conventional therapies. Understanding the cross-talk between leukemic cells and stroma is of interest for identifying signals supporting disease progression and for developing novel therapeutic strategies. Design and Methods: Different cell types, sharing a common mesenchymal origin and representative of various bone marrow components, were used to challenge the viability of leukemic cells in co-cultures and in contact-free culture systems. Using a bioinformatic approach we searched for genes shared by lineages prolonging leukemic cell survival and further analyzed their biological role in signal transduction experiments. Results: Human bone marrow stromal cells, fibroblasts, trabecular bone-derived cells and an osteoblastlike cell line strongly enhanced survival of leukemic cells, while endothelial cells and chondrocytes did not. Gene expression profile analysis indicated two soluble factors, hepatocyte growth factor and CXCL12, as potentially involved. We demonstrated that hepatocyte growth factor and CXCL12 are produced only by mesenchymal lineages that sustain the survival of leukemic cells. Indeed chronic lymphocytic leukemic cells express a functional hepatocyte growth factor receptor (c-MET) and hepatocyte growth factor enhanced the viability of these cells through STAT3 phosphorylation, which was blocked by a c-MET tyrosine kinase inhibitor. The role of hepatocyte growth factor was confirmed by its short interfering RNAmediated knock-down in mesenchymal cells. Conclusions: The finding that hepatocyte growth factor prolongs the survival of chronic lymphocytic leukemic cells is novel and we suggest that the interaction between hepatocyte growth factorproducing mesenchymal and neoplastic cells contributes to maintenance of the leukemic clone.
| Original language | English |
|---|---|
| Pages (from-to) | 1015-1023 |
| Number of pages | 9 |
| Journal | Haematologica |
| Volume | 96 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - Jul 2011 |
Fingerprint
Keywords
- Chronic lymphocytic leukemia
- Growth factors
- Mesenchymal stem cells
- Survival
ASJC Scopus subject areas
- Hematology
Cite this
An interaction between hepatocyte growth factor and its receptor (c-MET) prolongs the survival of chronic lymphocytic leukemic cells through STAT3 phosphorylation : A potential role of mesenchymal cells in the disease. / Giannoni, Paolo; Scaglione, Silvia; Quarto, Rodolfo; Narcisi, Roberto; Parodi, Manuela; Balleari, Enrico; Barbieri, Federica; Pattarozzi, Alessandra; Florio, Tullio; Ferrini, Silvano; Corte, Giorgio; de Totero, Daniela.
In: Haematologica, Vol. 96, No. 7, 07.2011, p. 1015-1023.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - An interaction between hepatocyte growth factor and its receptor (c-MET) prolongs the survival of chronic lymphocytic leukemic cells through STAT3 phosphorylation
T2 - A potential role of mesenchymal cells in the disease
AU - Giannoni, Paolo
AU - Scaglione, Silvia
AU - Quarto, Rodolfo
AU - Narcisi, Roberto
AU - Parodi, Manuela
AU - Balleari, Enrico
AU - Barbieri, Federica
AU - Pattarozzi, Alessandra
AU - Florio, Tullio
AU - Ferrini, Silvano
AU - Corte, Giorgio
AU - de Totero, Daniela
PY - 2011/7
Y1 - 2011/7
N2 - Background: Chronic lymphocytic leukemia cells are characterized by an apparent longevity in vivo which is lost when they are cultured in vitro. Cellular interactions and factors provided by the microenvironment appear essential to cell survival and may protect leukemic cells from the cytotoxicity of conventional therapies. Understanding the cross-talk between leukemic cells and stroma is of interest for identifying signals supporting disease progression and for developing novel therapeutic strategies. Design and Methods: Different cell types, sharing a common mesenchymal origin and representative of various bone marrow components, were used to challenge the viability of leukemic cells in co-cultures and in contact-free culture systems. Using a bioinformatic approach we searched for genes shared by lineages prolonging leukemic cell survival and further analyzed their biological role in signal transduction experiments. Results: Human bone marrow stromal cells, fibroblasts, trabecular bone-derived cells and an osteoblastlike cell line strongly enhanced survival of leukemic cells, while endothelial cells and chondrocytes did not. Gene expression profile analysis indicated two soluble factors, hepatocyte growth factor and CXCL12, as potentially involved. We demonstrated that hepatocyte growth factor and CXCL12 are produced only by mesenchymal lineages that sustain the survival of leukemic cells. Indeed chronic lymphocytic leukemic cells express a functional hepatocyte growth factor receptor (c-MET) and hepatocyte growth factor enhanced the viability of these cells through STAT3 phosphorylation, which was blocked by a c-MET tyrosine kinase inhibitor. The role of hepatocyte growth factor was confirmed by its short interfering RNAmediated knock-down in mesenchymal cells. Conclusions: The finding that hepatocyte growth factor prolongs the survival of chronic lymphocytic leukemic cells is novel and we suggest that the interaction between hepatocyte growth factorproducing mesenchymal and neoplastic cells contributes to maintenance of the leukemic clone.
AB - Background: Chronic lymphocytic leukemia cells are characterized by an apparent longevity in vivo which is lost when they are cultured in vitro. Cellular interactions and factors provided by the microenvironment appear essential to cell survival and may protect leukemic cells from the cytotoxicity of conventional therapies. Understanding the cross-talk between leukemic cells and stroma is of interest for identifying signals supporting disease progression and for developing novel therapeutic strategies. Design and Methods: Different cell types, sharing a common mesenchymal origin and representative of various bone marrow components, were used to challenge the viability of leukemic cells in co-cultures and in contact-free culture systems. Using a bioinformatic approach we searched for genes shared by lineages prolonging leukemic cell survival and further analyzed their biological role in signal transduction experiments. Results: Human bone marrow stromal cells, fibroblasts, trabecular bone-derived cells and an osteoblastlike cell line strongly enhanced survival of leukemic cells, while endothelial cells and chondrocytes did not. Gene expression profile analysis indicated two soluble factors, hepatocyte growth factor and CXCL12, as potentially involved. We demonstrated that hepatocyte growth factor and CXCL12 are produced only by mesenchymal lineages that sustain the survival of leukemic cells. Indeed chronic lymphocytic leukemic cells express a functional hepatocyte growth factor receptor (c-MET) and hepatocyte growth factor enhanced the viability of these cells through STAT3 phosphorylation, which was blocked by a c-MET tyrosine kinase inhibitor. The role of hepatocyte growth factor was confirmed by its short interfering RNAmediated knock-down in mesenchymal cells. Conclusions: The finding that hepatocyte growth factor prolongs the survival of chronic lymphocytic leukemic cells is novel and we suggest that the interaction between hepatocyte growth factorproducing mesenchymal and neoplastic cells contributes to maintenance of the leukemic clone.
KW - Chronic lymphocytic leukemia
KW - Growth factors
KW - Mesenchymal stem cells
KW - Survival
UR - http://www.scopus.com/inward/record.url?scp=79960002693&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79960002693&partnerID=8YFLogxK
U2 - 10.3324/haematol.2010.029736
DO - 10.3324/haematol.2010.029736
M3 - Article
C2 - 21486864
AN - SCOPUS:79960002693
VL - 96
SP - 1015
EP - 1023
JO - Haematologica
JF - Haematologica
SN - 0390-6078
IS - 7
ER -